Zealand Pharma A/S ZEALAND PHARMA AKTIESELSKABET ORD SHS
Zealand Pharma A/S ZEALAND PHARMA.../ DK0060257814 /
0NZU
9/11/2024 6:38:40 PM
|
Chg.
+48.50
|
Volume |
Bid9/11/2024 |
Ask9/11/2024 |
High |
Low |
902.50DKK
|
+5.68%
|
5,898 Turnover: 5.27 mill. |
-Bid Size: - |
-Ask Size: - |
905.50 |
851.50 |
Business description
Zealand Pharma A/S is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products.
Management board & Supervisory board
CEO |
Adam Steensberg |
Management board |
Henriette Wennicke, David Kendall, Ivan Møller, Christina Sonnenborg Bredal , Ravinder Chahil |
Supervisory board |
Martin Nicklasson, Kirsten A. Drejer, Jeffrey Berkowitz, Bernadette Connaughton, Leonard Kruimer, Alain Munoz, Michael John Owen, Frederik Barfoed Beck, Anneline Nansen, Louise Gjelstrup, Jens Peter Stenvang, Enrique Conterno, Elaine Sullivan |
Company data
Name: |
Zealand Pharma A/S |
Address: |
Sydmarken 11,2860 Søborg |
Phone: |
- |
Fax: |
- |
E-mail: |
+45 88 77 36 00
|
Internet: |
info@zealandpharma.com |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
- |
End of financial year: |
12/31 |
Free Float: |
- |
IPO date: |
- |
Company calendar
CW 45 | 11/7/2024
Interim Report 3rd Quarter/9 Months
|